Skip to main content
SunBio, Inc. logo

SunBio, Inc. — Investor Relations & Filings

Ticker · 067370 ISIN · KR7067370007 KO Manufacturing
Open in API
Filings indexed 213 across all filing types
Latest filing 2018-11-21 Proxy Solicitation & In…
Country KR South Korea
Listing KO 067370

About SunBio, Inc.

http://www.sunbio.com/

SunBio, Inc. is a biotechnology company that develops biosimilars, biopharmaceuticals, and medical devices. The company's core activities are based on its proprietary PEGylation technology, a process that modifies molecules to enhance their therapeutic properties. SunBio's product portfolio includes PEG reagents for research and drug delivery, as well as biopharmaceutical candidates. Key development projects include MucoPEG™, a muco-adhesive hydrogel, and SBX, an artificial blood substitute. The company positions itself as a specialist in PEGylation, creating advanced therapeutic products for a global market.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for SunBio, detailing the date, time, location, and the agenda item regarding the appointment of an outside director. This type of document, which provides information to shareholders to request their participation and vote on specific agenda items, falls under the category of Proxy Solicitation & Information Statement.
2018-11-21 Korean
기업설명회(IR)개최결과
Investor Presentation Classification · 1% confidence The document is a short, structured announcement (870 characters) confirming the results of an Investor Relations (IR) meeting held by SunBio. It provides details on the date, location, attendees, and confirms that the IR materials were distributed at the event and uploaded to the Korea Exchange (KRX) system. Since it is a brief notification regarding the occurrence of an event and the availability of materials rather than the presentation deck itself, it falls under the category of a Report Publication Announcement (RPA).
2018-10-18 Korean
기업설명회(IR)개최
Investor Presentation Classification · 1% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, time, location, purpose, and agenda for the upcoming event. Since it is an announcement of an event rather than the presentation materials themselves or a comprehensive financial report, and it does not fit into specific categories like M&A or dividend notices, it is classified as a general regulatory filing/announcement.
2018-10-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.